Investigating the functions and molecular mechanisms of DTX3L in cancer progression

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• E3 ubiquitin ligases mediate protein degradation, a critical process in tumor research.
• DTX3L, a Deltex family E3 ligase, is implicated in the development and progression of various cancers.
• Understanding DTX3L's role is crucial for advancing cancer therapy.

Purpose of the Study:

• To systematically review current research on DTX3L in malignant tumors.
• To analyze DTX3L's regulatory mechanisms and functions in cancer.
• To evaluate DTX3L as a potential therapeutic target for cancer treatment.

Main Methods:

• Literature review of cutting-edge research findings on DTX3L.
• Analysis of DTX3L's involvement in cancer development and progression.
• Examination of DTX3L's regulatory mechanisms (epigenetics, signaling pathways, protein interactions).

Main Results:

• DTX3L regulates critical biological processes including cell proliferation, cell cycle, migration, invasion, and apoptosis.
• DTX3L exhibits unique substrate selectivity, making it a promising target for cancer therapy.
• Further validation is needed for clinical translation of DTX3L-targeted strategies.

Conclusions:

• DTX3L plays a significant role in various malignant tumors.
• DTX3L is a potential target for precision cancer diagnosis and treatment.
• Bridging basic research and clinical applications, DTX3L holds promise for future cancer therapies.